fashion -WSS

fashion

author：entertainment 2025-10-02 04:07:56 - browse：373

Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and Drug Administration requested additional data to support including female patients of childbearing potential. The move left many researchers wondering whether the specter of accidental germline transmission — which haunted early gene therapy trials — had now risen over the field of gene editing.

Over the weekend, Intellia sought to assure the gene editing community that no such thing is happening. At a meeting at Cold Spring Harbor Laboratory that drew more than 400 of the field’s top scientists, the company shared more detailed information about studies it has conducted to assess the risks that renegade CRISPR components could be getting into an egg or sperm. These studies demonstrate “that there’s no evidence of vertical germline transmission of those edits,” Jonathan Phillips, head of pharmacology and toxicology at Intellia, said during a presentation Saturday.

Intellia is one of the leading companies working to advance in vivo gene editing therapies. In a landmark study published in the New England Journal of Medicine in 2021, Intellia revealed data from six patients in its trial for a transthyretin amyloidosis therapy — showing for the first time that it was possible to precisely alter the DNA of particular cells within the human body to treat disease with a one-time infusion of CRISPR. Included in the supplementary material was a redacted version of the company’s package requesting authorization to start its clinical trial. It noted that during toxicology studies in non-human primates, Intellia scientists discovered that editing had taken place at low levels in organs other than the liver, including the spleen and adrenal glands. In three out of 12 female monkeys, they also found editing in the animals’ ovaries.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： A bus careens into a gulch in southern Mexico, leaving 27 people dead

WSS

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

Pregnancy ages women, but effects reverse after delivery

Steward Health Care expansion into Malta flopped

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

explore

fashion

entertainment

Supreme Court strikes down use of affirmative action

Adam's Take: Intra

How to save PrEP access — and even expand it

Steward Health Care expansion into Malta flopped

Wildfire smoke exposes gaps in outdoor worker protections

Diabetes management: Digital health tools fall short, study says

Malaria cases in Florida and Texas: Here’s what you need to know

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Affirmative action in medical school literally saved lives

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

hotspot

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

Pentagon will tighten controls on classified information after Discord leak

Asbestos ban is immediate, but health effects will linger for decades

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

What Kate Middleton's cancer revelation might teach the world

This gene therapy has record $4.25 million price. It's saved children.

Wikipedia

hotspot

knowledge

focus